Perioperative and oncologic outcomes with robotic vs. open radical prostatectomy
Canadian Urological Association Journal · 2026-10-19 · 21 (2)
DOI: 10.5489/cuaj.9708 ↗Abstract
Introduction: Robotic-assisted radical prostatectomy (RARP) is the predominant surgical treatment for localized prostate cancer worldwide, but adoption has been slower in Ontario due to funding constraints. This setting enables population-level comparison of RARP and open radical prostatectomy (ORP). We evaluated perioperative and short-term oncologic outcomes for men undergoing radical prostatectomy in Ontario between April 2017 and March 2024. Methods: We conducted a retrospective cohort study of all patients who underwent publicly funded radical prostatectomy for localized prostate cancer. Co-primary outcomes were blood transfusion rates and hospital length of stay (LOS). Secondary outcomes included operative time, 30-day readmission, vesico-urethral anastomosis stenosis (VUAS) requiring intervention, surgical wait time, and travel distance. Exploratory outcomes included 30-day mortality, positive surgical margins (PSM), and receipt of pelvic radiation post-prostatectomy. Results: Among 15 073 patients, 6645 (44.1%) underwent RARP and 8428 (55.9%) ORP. Median followup was 36.8 months after RARP and 38.8 months after ORP. RARP was associated with lower transfusion rates (1.2% vs. 4.7%, p
EUVIMED